Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v19-EN Version v4-EN
Language English English
Date Updated 2022-06-21 2022-05-16
Drug Identification Number 02086026 02086026
Brand name FLORINEF FLORINEF
Common or Proper name FLUDROCORTISONE 21-ACETATE FLUDROCORTISONE 21-ACETATE
Company Name PALADIN LABS INC. PALADIN LABS INC.
Ingredients FLUDROCORTISONE 21-ACETATE FLUDROCORTISONE 21-ACETATE
Strength(s) 0.1MG 0.1MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 Tabs 100 Tabs
ATC code H02AA H02AA
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2022-04-21 2022-04-21
Actual start date
Estimated end date 2022-06-22 2022-05-19
Actual end date 2022-06-20
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Resolved - product to remain on allocation based on historical demand until end of September to ensure fair distribution
Health Canada comments